当前位置: X-MOL 学术J. Clin. Endocrinol. Metab. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans
The Journal of Clinical Endocrinology & Metabolism ( IF 5.0 ) Pub Date : 2021-07-23 , DOI: 10.1210/clinem/dgab546
Martina Recalde 1, 2 , Andrea Pistillo 1 , Sergio Fernandez-Bertolin 1 , Elena Roel 1, 2 , Maria Aragon 1 , Heinz Freisling 3 , Daniel Prieto-Alhambra 4, 5 , Edward Burn 1, 4 , Talita Duarte-Salles 1
Affiliation  

Abstract
Context
A comprehensive understanding of the association between body mass index (BMI) and COVID-19 is still lacking.
Objective
To investigate associations between BMI and risk of COVID-19 diagnosis, hospitalisation with COVID-19, and death after a COVID-19 diagnosis or hospitalisation (subsequent death), accounting for potential effect modification by age and sex.
Design
Population-based cohort study.
Setting
Primary care records covering >80% of the Catalan population, linked to region-wide testing, hospital, and mortality records from March to May 2020.
Participants
Adults (≥18 years) with at least one measurement of weight and height.
Main outcome measures
Hazard ratios (HR) for each outcome.
Results
We included 2 524 926 participants. After 67 days of follow-up, 57 443 individuals were diagnosed with COVID-19, 10 862 were hospitalised with COVID-19, and 2467 had a subsequent death. BMI was positively associated with being diagnosed and hospitalised with COVID-19. Compared to a BMI of 22kg/m 2, the HR (95%CI) of a BMI of 31kg/m 2 was 1.22 (1.19-1.24) for diagnosis, and 1.88 (1.75-2.03) and 2.01 (1.86-2.18) for hospitalisation without and with a prior outpatient diagnosis, respectively. The association between BMI and subsequent death was J-shaped, with a modestly higher risk of death among individuals with BMIs ≤19kg/m 2 and a more pronounced increasing risk for BMIs ≥40kg/m 2. The increase in risk for COVID-19 outcomes was particularly pronounced among younger patients.
Conclusions
There is a monotonic association between BMI and COVID-19 diagnosis and hospitalisation risks, but a J-shaped one with mortality. More research is needed to unravel the mechanisms underlying these relationships.


中文翻译:

体重指数和 COVID-19 诊断、住院和死亡风险:对 2 524 926 名加泰罗尼亚人的队列研究

摘要
语境
仍然缺乏对体重指数 (BMI) 与 COVID-19 之间关联的全面了解。
客观的
调查 BMI 与 COVID-19 诊断、COVID-19 住院以及 COVID-19 诊断或住院后死亡(随后死亡)风险之间的关联,并考虑年龄和性别的潜在影响。
设计
基于人群的队列研究。
环境
覆盖超过 80% 的加泰罗尼亚人口的初级保健记录,与 2020 年 3 月至 2020 年 5 月的全区域检测、医院和死亡率记录相关联。
参与者
至少有一项体重和身高测量值的成人(≥18 岁)。
主要观察指标
每个结果的风险比 (HR)。
结果
我们纳入了 2 524 926 名参与者。经过 67 天的随访,57443 人被诊断出患有 COVID-19,10862 人因 COVID-19 住院,2467 人随后死亡。BMI 与 COVID-19 的诊断和住院呈正相关。相比的22公斤/ m的BMI 2中,HR31千克的BMI的(95%CI)/米2为1.22(1.19-1.24),用于诊断,和1.88(1.75-2.03)和2.01(1.86-2.18),用于分别在没有和有先前门诊诊断的情况下住院。BMI和随后的死亡之间的相关性的J形,与死亡的与的BMI≤19kg/米个体中温和高风险2和的BMI≥40kg/ m的更明显增加风险2. COVID-19 结果风险的增加在年轻患者中尤为明显。
结论
BMI 与 COVID-19 诊断和住院风险之间存在单调关联,但与死亡率呈 J 型关联。需要更多的研究来解开这些关系背后的机制。
更新日期:2021-07-24
down
wechat
bug